Considerations in the development of lung cancer screening tools.
Mulshine
J L
JL
Navy Medical Oncology Branch, National Cancer Institute, Bethesda, MD.
Tockman
M S
MS
Smart
C R
CR
D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control* / Q000628:therapy; D008403:Mass Screening / Q000379:methods* / Q000639:trends; D009316:National Institutes of Health (U.S.); D014481:United States